It is important to note here that increased serum levels of survivin have been linked to increased cancer risk (Liping et al., 2010), rendering this protein as a potential biomarker in cancer (Yin et al., 2006; Xie et al., 2016; Martínez-Sifuentes et al., 2022). This evidence concerns the gene BIRC5 and cancer.